Drug screening identifies tazarotene and bexarotene as therapeutic agents in Multiple Sulfatase Deficiency
Ontology highlight
ABSTRACT: We analysed differences in gene expression upon treatment of MSD patient fibroblast lines with either tazarotene or adapalene and DMSO control (untreated condition)
ORGANISM(S): Homo sapiens
PROVIDER: GSE205555 | GEO | 2022/11/04
REPOSITORIES: GEO
ACCESS DATA